FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Hippel James
  2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [TECH] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CFO
(Last)
(First)
(Middle)
614 MCKINLEY PLACE NE		 3. Date of Earliest Transaction (Month/Day/Year)
07/23/2024
(Street)

MINNEAPOLIS, MN 55413		 4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/23/2024   M   35,000 A $ 31.26 107,284 (1) D  
Common Stock 07/23/2024   F   24,282 D $ 77.77 83,002 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 31.26 07/23/2024   M     35,000   (2) 08/09/2024 Common Stock 35,000 $ 0 106,867 D  
Stock Options (Right to Buy) $ 44.33               (2) 08/08/2025 Common Stock 168,620   168,620 D  
Stock Options (Right to Buy) $ 47.6               (2) 08/07/2026 Common Stock 186,068   186,068 D  
Stock Options (Right to Buy) $ 66.97               (2) 08/05/2027 Common Stock 90,740   90,740 D  
Stock Options (Right to Buy) $ 66.97               (3) 08/05/2027 Common Stock 76,588   76,588 D  
Restricted Stock Units (4)               (5)   (5) Common Stock 7,780   7,780 D  
Performance Stock Options (Right to Buy) $ 120.46               (5) 08/06/2028 Common Stock 30,400   30,400 D  
Stock Options (Right to Buy) $ 120.46               (6) 08/06/2028 Common Stock 40,536   40,536 D  
Restricted Stock Units (4)               (7)   (7) Common Stock 10,912   10,912 D  
Performance Stock Options (Right to Buy) $ 94.52               (7) 08/15/2029 Common Stock 33,916   33,916 D  
Stock Options (Right to Buy) $ 94.52               (8) 08/15/2029 Common Stock 45,220   45,220 D  
Restricted Stock Units (4)               (9)   (9) Common Stock 13,865   13,865 D  
Performance Stock Options (Right to Buy) $ 84.61               (9) 08/15/2030 Common Stock 37,314   37,314 D  
Stock Options (Right to Buy) $ 84.61               (10) 08/15/2030 Common Stock 45,923   45,923 D  
Restricted Stock Units (4)               (11)   (11) Common Stock 26,318   26,318 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Hippel James
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413		       CFO  

Signatures

 /s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed   07/25/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Reporting Person's direct ownership has been increased by 400 shares pursuant to a clerical error in a previous filing.
(2) Fully exercisable.
(3) Options to purchase 19,147 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
(4) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
(5) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(6) Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
(7) Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(8) Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
(9) Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(10) Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
(11) 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.